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Abstract
Over-The-Counter Analgesics (OTCA) account for over a fifth of Irish pharmacy sales. Little is known
about patterns of use, specifically in children. This study investigated parents’ use of OTCAs in children.
A questionnaire exploring use of OTCAs and knowledge of side-effects was distributed to guardians of
children attending three GP surgeries in South of Ireland from June-September 2010. The questionnaire
was completed by 183 parents (response rate 95%). Many respondents (n=121, 66.1%) were using
analgesics when not required or using an inappropriate analgesic for a child’s symptom. Private patients
demonstrated better use (n=31, 40%) than those with Medical Cards (n=18, 22.5%) (p=0.016).
Identification of potential side-effects was poor, with drowsiness (n=88, 49%), rash (n=39, 22%) and
nausea (n=32, 18%) listed as potential side-effects. Inappropriate use of OTCAs is prevalent in Irish
children. Parents need more information and guidance on their use.
 
Introduction
Over The Counter analgesics (OTCA) are among the most widely sold products in pharmacies, accounting for over a fifth of pharmacy
sales in Ireland1. Pain, pyrexia and inflammatory musculoskeletal/joint conditions are the indications for OTCAs. Oral administration
is the most common route of administration, but suppositories are preferred in vomiting children. They can be purchased directly
from a pharmacy assistant/sales assistant without formal consultation. In an American study, over half of children under 3 years
used OTCAs in the month of the study period2 and other studies show that parents/guardians often choose to medicate their children
for minor illnesses without first seeking professional advice3,4. Parents are unsure of the correct dosing and possible side-effects of
these medications5, and over half of all febrile children attending an Emergency Department in a US study, had previously received
inaccurate doses of paracetamol or ibuprofen6. The 2010 Annual Report of the National Poisons Information Centre of Ireland,
showed that of the 9330 enquiries regarding human poisoning, half concerned children less than 10 years of age7. Paracetamol was
the most common drug reported followed by ibuprofen. While most paracetamol toxicity occurs as a result of a single overdose,
toxicity can also occur as a result of numerous or repeated supra-therapeutic doses given at indicated intervals. Toxicity can be
difficult to diagnose as early symptoms may mimic the underlying illness i.e. nausea, vomiting, anorexia and diaphoresis. 
OTCA use, even when indicated and used appropriately, may have long-term health implications. There may be a relationship
between paracetamol use in infancy and the development of atopic conditions8,9. Prophylactic use of paracetamol at the time of
immunization has been shown to significantly reduce the primary antibody response to all serotypes of PCV 10 and to haemophilus
influenza type b, diphtheria, tetanus and pertactin antigens10. For this reason, the Health Service Executive (HSE) of Ireland
currently only recommends the use of paracetamol/ibuprofen for pyrexia >39.5°C or if a child has a large local reaction post-
vaccination11. Several studies have described a relationship between OTCA use in children and socio-economic class, education and
race2,12. Caucasian parents, parents with a higher level of education, and those with a higher income are more likely to use OTCAs.
This increased use is also more prevalent among children whose parents do not have health insurance2. In addition, OTCA use for
minor illnesses or for behavioural changes is more common in children whose parents work full-time12. 
While children in Ireland commonly use OTCAs, little is known of their patterns of use; this study investigated parental use of OTCAs
in children in Ireland.
Methods
A cross-sectional survey of parents and guardians with at least one child was undertaken during a 4-month period (June to
September 2010) across three family physician surgeries in the South of Ireland. Reception staff at each of the sites invited all
parents/guardians attending the medical centres with their children for appointments to complete a questionnaire. This was returned
to the secretary in an anonymous, sealed envelope. A questionnaire was designed based on that of Allotey13. It was piloted and
adjusted accordingly. Demographic data collected included age and marital status of parents/guardians, number of children under
their care, health insurance status and age on leaving education. Questions regarding preferred types of OTCAs, knowledge of
potential side effects and use in relation to immunisation were included. Use of OTCAs was assessed using 10 vignettes. Vignettes
were constructed by a family doctor and paediatrician to reflect commonly encountered clinical scenarios. Participants indicated
which analgesic, if any they would use in a particular situation. Participants were given the option of leaving a comment. 
Results were dichotomized into appropriate or inappropriate use. Inappropriate use was defined as use of an analgesic that
potentially did not optimise symptom control (e.g. oral medicines if a child is vomiting, and vice versa using suppositories if a child
has diarrhoea) or use of analgesics not indicated (e.g. if a child is misbehaving, to induce sleep or to calm a child on long car
journeys). Data was analysed with SPSS using a combination of both descriptive and inferential statistics. Chi squares were used to
predict statistical relationships in which p-values <0.05 were taken to indicate a significant relationship. The Clinical Research Ethics
Committee of the Cork Teaching Hospitals granted ethical approval.
Results
183 parents or guardians participated in this study; their mean age was 34 years (range 18-60 years). 9 parents declined to
participate, citing time pressure. No questionnaire had more than 2 unanswered questions and all were included in subsequent
analysis. All questions were answered in over 95% of questionnaires except educational status (74%) and insurance status (90%). 
Parents with and without health insurance, and those achieving each educational milestone were equally represented. Almost two
thi d (62 3%) h d th hild d 83% f ti i t i di t d th t th i hild/ hild tt d d “Child i d ”
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thirds (62.3%) had more than one child and over 83% of participants indicated that their child/children attended a “Child minder”,
Montessori, Pre-school or Primary school.  An overview of results is given in 
*Results were calculated as percentage of total population surveyed in cases of partial completion.
Measurement of temperature
Eighty-six percent of participants reported using a thermometer to measure temperature prior to administering OTCAs. Many used
other methods such as feeling a child’s forehead (44.8%), instinct (22.9%) or the child’s behaviour (20.7%) to determine whether or
not the child was pyrexial. 
Source of medicines information
24% consulted a pharmacist, 19% a doctor, 7% a nurse, 86% always consulted the label prior to giving OTCAs.
Preparations Used
Oral formulations were most frequently used.  Suppositories were used by 20.4% of parents/guardians. Of those not using
suppositories, over half stated that they have never had reason to use them and would only use suppositories as a last resort as they
felt they were “stronger” than the oral alternatives: 15.7% didn’t like administrating them and 2.2% of respondents had “never
heard of them”. 
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*Results were calculated as percentage of total population surveyed in cases of partial completion.
Clinical vignettes
Two thirds of respondents were using analgesics inappropriately, as determined by the clinical scenarios. 54% indicated that they
would use the incorrect analgesic for a particular symptom and a third of respondents use OTC analgesics when there are no
indications for use. Patients with private health insurance were more likely to have appropriate patterns of use (40%) compared to
Medical Card/Doctor-Only Card holders (22.5%) (p=0.016). 
Side-effects
Most parents (92.7%) purported that their child had never experienced side effects from OTCAs. However identification of potential
side effects was poor, with drowsiness (49%), rash (22%) and nausea (18%) listed as the most commonly observed side effects.
Approximately one in ten parents incorrectly indicated symptoms such as high temperature, headache and irritability as possible side
effects. Almost 20% of parents/guardians said they would routinely give OTCA’s to their children prior to vaccinations.
Discussion
This study describes patterns of use of OTCAs in a paediatric population in Ireland. Pharmacies are the most common place of
purchase. Parental misconceptions regarding correct route of administration, appropriate use, knowledge of side effects and use
around time of vaccination, were observed. Previous studies have shown that many parents use OTCAs for unlicensed indications13.
This was shown in our study, where one in three parents/guardians used OTCAs in situations in which they are not clinically
indicated. In these instances, the OTCAs were used predominately for parental misconceived side effects, in particular sedation. Irish
parents without private health insurance were more likely to incorrectly use OTCAs. This contrasts with an American study by Kogan
et al2, which reported a higher level of incorrect use of OTCAs among those with private health insurance. Despite the fact that over
90% of OTCAs are purchased from pharmacies, only a quarter of parents/guardians regularly consulted a pharmacist prior to
administration of OTCA. In addition, 14% do not routinely consult the label of the product prior to administration. Restricting OTCA
availability to pharmacies, accompanied by a discussion with a pharmacist prior to sale, similar to measures implemented by the
Pharmaceutical Society of Ireland (PSI) to increase awareness and reduce consumption of codeine containing products, could
potentially result in improved use of OTCA amongst the Irish population. 
In view of recent data assessing analgesic use and impaired immunological response to immunizations, it is reassuring that the
majority of parents adhere to evidence-based guidelines and do not use OTCAs around the time of vaccination. Nevertheless, it
remains common, with almost one fifth of those surveyed routinely administering OTCA prior to immunizations. This study consisted
of almost 200 participants recruited from both urban and rural family practice surgeries, consistent with the current structure of
primary care models in Ireland. As with all questionnaires, this study may have experienced recall bias in relation to OTCA use as it
relied on a self-report method of data collection. In addition, the questionnaire was largely quantitative, such that explanations and
causation factors for some of the research findings may not be generalisable. 
In conclusion, incorrect OTCA use is prevalent in the Irish paediatric population. We recommend that all sellers of OTCAs should be
aware of their responsibilities and use the point of sale to provide and reinforce correct information to parents. Finally, all healthcare
providers should enquire about OTCA use at routine healthcare visits allowing for opportunistic parental education. 
Correspondence: M Kelly
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